With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot, ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, "Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

His prior experience spans investment banking, management consulting and extensive partnering/M&A work at large medical device and biopharmaceutical companies, including Medtronic, Smith & Nephew, and ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

Major companies in the market include Coloplast, Medtronic, Convatec, Hollister Incorporated, B. Braun Melsungen AG, Axonics Inc, Dentsply Sirona, Consure Medical, MBH-International A/S, and Renew ...

Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

Savy investors profit in times of crisis. The World Health Organization (WHO), Food and Drug Administration (FDA) an ...